Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305K Hold
843
0.06% 224
2026
Q1
$297K Sell
843
-843
-50% -$301K 0.06% 211
2025
Q4
$552K Buy
1,686
+896
+113% +$284K 0.06% 214
2025
Q3
$223K Sell
790
-152
-16% -$44.1K 0.05% 228
2025
Q2
$263K Buy
942
+152
+19% +$43.1K 0.06% 213
2025
Q1
$246K Sell
790
-3
-0.4% -$886 0.06% 216
2024
Q4
$207K Hold
793
0.05% 248
2024
Q3
$256K Hold
793
0.11% 141
2024
Q2
$248K Buy
+793
New +$233K 0.12% 135
2024
Q1
Sell
-693
Closed -$200K 236
2023
Q4
$200K Buy
+693
New +$189K 0.07% 216

Other funds holding AMGN

BCS Wealth Management's AMGN Position: Q2 2026 in Review

BCS Wealth Management held its Amgen (AMGN) position steady in Q2 2026 at 843 shares worth $305K. The position accounts for 0.06% of the portfolio, ranked #224.

BCS Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $552K in Q4 2025. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • BCS Wealth Management held 843 shares of Amgen worth $305K as of Q2 2026.
  • BCS Wealth Management left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.06% of BCS Wealth Management's portfolio in Q2 2026, its #224 holding.
  • BCS Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • BCS Wealth Management's Amgen position peaked at $552K in Q4 2025.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on BCS Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.